66255-16-1 Usage
Description
S-Methyl-D-Cys-OH, also known as S-methyl-D-cysteine, is a chemical compound derived from the amino acid cysteine, featuring a sulfur atom. It has been recognized for its potential antioxidant properties, including the ability to scavenge free radicals, thereby protecting cells from oxidative damage. S-Methyl-D-Cys-OH's capacity to modulate detoxification pathways also positions it as a candidate for therapeutic applications in conditions associated with oxidative stress.
Uses
Used in Pharmaceutical Applications:
S-Methyl-D-Cys-OH is used as a therapeutic agent for conditions related to oxidative stress due to its antioxidant properties and its ability to protect cells from oxidative damage.
Used in Nutritional Supplements:
In the nutrition industry, S-Methyl-D-Cys-OH is used as a dietary supplement to support overall health by providing antioxidant benefits and potentially enhancing detoxification processes in the body.
Used in Cosmetic Products:
S-Methyl-D-Cys-OH is utilized in cosmetic formulations for its potential to protect the skin from oxidative damage, which can contribute to aging and other skin conditions, thereby promoting skin health and vitality.
These applications highlight the versatility of S-Methyl-D-Cys-OH across different industries, where its unique properties can be harnessed to improve health, wellness, and product efficacy.
Check Digit Verification of cas no
The CAS Registry Mumber 66255-16-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,2,5 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 66255-16:
(7*6)+(6*6)+(5*2)+(4*5)+(3*5)+(2*1)+(1*6)=131
131 % 10 = 1
So 66255-16-1 is a valid CAS Registry Number.
InChI:InChI=1/C4H9NO2S/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m1/s1
66255-16-1Relevant articles and documents
CARBOXAMIDE DERIVATIVES AND THEIR USE AS FACTOR XA INHIBITORS
-
Page/Page column 32-33, (2008/06/13)
The invention relates to the novel compounds of formula (I), wherein R1, D, X, W, Y and T are defined as in claim 1, for example (II). The novel compounds inhibit coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
